Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("CLOTRIMAZOLE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 619

  • Page / 25
Export

Selection :

  • and

Separation and determination of clotrimazole, methylparaben and propylparaben in pharmaceutical preparation by micellar electrokinetic chromatographyHAMOUDOVA, Rafifa; POSPISILOVA, Marie; KAVALIROVA, Andrea et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 1, pp 215-219, issn 0731-7085, 5 p.Article

Influence of ionising irradiation on clotrimazole in the solid stateMARCINIEC, B; DETTLAFF, K; NASKRENT, M et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 50, Num 4, pp 675-678, issn 0731-7085, 4 p.Conference Paper

Antimicrobial Activity of lodoquinol 1%-Hydrocortisone Acetate 2% Gel Against Ciclopirox and ClotrimazoleBURNETT, Bruce P; MITCHELL, Calvin M.Cutis (New York, NY). 2008, Vol 82, Num 4, pp 273-280, issn 0011-4162, 8 p.Article

Clotrimazole as a pharmaceutical: past, present and futureCROWLEY, P. D; GALLAGHER, H. C.Journal of applied microbiology (Print). 2014, Vol 117, Num 3, pp 611-617, issn 1364-5072, 7 p.Article

NEW ANTIFUNGAL DRUGHOLT RJ.1975; DRUGS; SWITZ.; DA. 1975; VOL. 9; NO 6; PP. 401-405; BIBL. 14REF.Article

Incorporation of clotrimazole in Ordered Mesoporous Silica by supercritical CO2GIGNONE, Andrea; MANNA, Luigi; RONCHETTI, Silvia et al.Microporous and mesoporous materials. 2014, Vol 200, pp 291-296, issn 1387-1811, 6 p.Article

Toxicity of the pharmaceutical clotrimazole to marine microalgal communitiesPORSBRING, Tobias; BLANCK, Hans; TJELLSTRÖM, Henrik et al.Aquatic toxicology. 2009, Vol 91, Num 3, pp 203-211, issn 0166-445X, 9 p.Article

METASTATISCHE OPHTHALMIE NACH CANDIDASEPSIS. ERFAHRUNGEN MIT DEM NEUEN ORALEN ANTIMYKOTIKUM BAY B 5097 = OPHTALMIE METASTATIQUE APRES SEPTICEMIE A C. EXPERIENCES AVEC LE NOUVEL ANTIMYCOTIQUE ORAL BAY B 5097FREUND J; RUEGER K; MALCHOW H et al.sdKLIN. MONATSBL. AUGENHEILKDE; DTSCH.; DA. 197; VOL. 161; NO 1; PP. 82-88; ABS. ANGL.; BIBL. 10REF.Serial Issue

Functional roles of YPT31 and YPT32 in clotrimazole resistance of Saccharomyces cerevisiae through effects on vacuoles and ATP-binding cassette transporter(s)TSUJIMOTO, Yoshiyuki; TAKASE, Daisuke; OKANO, Hajime et al.Journal of bioscience and bioengineering. 2013, Vol 115, Num 1, pp 4-11, issn 1389-1723, 8 p.Article

Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?DAS, Surajit; WAI KIONG NG; TAN, Reginald B. H et al.European journal of pharmaceutical sciences. 2012, Vol 47, Num 1, pp 139-151, issn 0928-0987, 13 p.Article

Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilmsLAFLEUR, Michael D; LUCUMI, Edinson; NAPPER, Andrew D et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 4, pp 820-826, issn 0305-7453, 7 p.Article

Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivoGRGIC, Ivica; EICHLER, Ines; HEINAU, Philipp et al.Arteriosclerosis, thrombosis, and vascular biology. 2005, Vol 25, Num 4, pp 704-709, issn 1079-5642, 6 p.Article

Development of a controlled release formulation based on SLN and NLC for topical clotrimazole deliverySOUTO, E. B; WISSING, S. A; BARBOSA, C. M et al.International journal of pharmaceutics. 2004, Vol 278, Num 1, pp 71-77, issn 0378-5173, 7 p.Article

Etiological significance of Candida albicans in otitis externaJADHAV, Vijay J; PAL, M; MISHRA, G. S et al.Mycopathologia (1975). 2003, Vol 156, Num 4, pp 313-315, issn 0301-486X, 3 p.Article

Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazoleKHALID, M. Humayun; TOKUNAGA, Yoshiharu; DIV, M et al.Journal of neurosurgery. 2005, Vol 103, Num 1, pp 79-86, issn 0022-3085, 8 p.Article

A DOUBLE-BLIND COMPARISON OF SULCONAZOLE NITRATE 1% CREAM WITH CLOTRIMAZOLE 1% CREAM IN THE TREATMENT OF DERMATOPHYTOSESLASSUS A; FORSTROM S; SALO O et al.1983; BRITISH JOURNAL OF DERMATOLOGY (1951); ISSN 0007-0963; GBR; DA. 1983; VOL. 108; NO 2; PP. 195-198; BIBL. 2 REF.Article

DOSAGE DU PRINCIPE ACTIF DANS DES PREPARATIONS CONTENANT DU MICONAZOLE ET DU CLOTRIMAZOLESZABOLCS L.1976; ACTA PHARM. HUNGAR.; HONGR.; DA. 1976; VOL. 46; NO 1; PP. 43-48; ABS. RUSSE ANGL. ALLEM.Article

SPERIMENTAZIONE CLINICA DI UN NUOVO PRODOTTO ANTIMICOTICO: BAY B 5097 (CANESTEN) = EXPERIMENTATION CLINIQUE D'UN NOUVEL ANTIMYCOTIQUE: BAY B 5097 (CANESTEN)CAVALLAZZI G; CESARANI A; LASAGNI A et al.1975; MINERVA OTORINOLARINGOL.; ITAL.; DA. 1975; VOL. 25; NO 4; PP. 281-294; ABS. ANGL.; BIBL. 11 REF.Article

PULMONAL KRYPTOKOKKOSE: TO TILFAELDE BEHANDLET MED CLOTRIMAZOLE = CRYPTOCOCCOSE PULMONAIRE. COMPTE RENDU DE 2 CAS TRAITES PAR LE CLOTRIMAZOLEMOSSING NB; RAHBEK A.1972; UGESK. LAEGER; DANM.; DA. 1972; VOL. 134; NO 37; PP. 1952-1954; ABS. ANGL.; BIBL. 15 REF.Serial Issue

METASTATISCHE OPHTHALMIE NACH CANDIDASEPSIS. ERFAHRUNGEN MIT DEM NEUEN ORALEN ANTIMYKOTIKUM BAY B 5097 = OPHTALMIE METASTATIQUE APRES SEPTICEMIE A C. EXPERIENCES AVEC LE NOUVEL ANTIMYCOTIQUE ORAL BAY B 5097FREUND J; RUEGER K; MALCHOW H et al.1972; KLIN. MONATSBL. AUGENHEILKDE; DTSCH.; DA. 1972; VOL. 161; NO 1; PP. 82-88; ABS. ANGL.; BIBL. 10REF.Serial Issue

ERFAHRUNGEN BEI DER THERAPIE DER GRANULOMATOESEN CANDIDA-MYKOSE DER KINDER MIT CLOTRIMAZOL (BAYB5097) = RESULTATS DU TRAITEMENT, PAR LE CLOTRIMAZOLE (BAYB5097), DES MYCOSES GRANULOMATEUSES A C CHEZ L'ENFANTMEINHOF W.1973; DERMATOL. MONATSSCHR.; DTSCH.; DA. 1973; VOL. 159; NO 4; PP. 433-435; BIBL. 2REF.; (GES. MED. MYKOL. DTSCH. DEMOKR. REPUB. VI. TAG. INT. BETEILIGUNG; LEIPZIG; 1972)Conference Paper

AKUTE TOXIZITAET UND LOKALE VERTRAEGLICHKEIT VON CLOTRIMAZOL. ZUSAMMENFASSUNG DER VERSUCHSERGEBNISSE = LA TOXICITE AIGUE ET LA TOLERANCE LOCALE DU CLOTRIMAZOLE. RESUME DES RESULTATS DES RECHERCHESTETTENBORN D.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 8; PP. 1272-1276; ABS. ANGL.; BIBL. 1/2P.Serial Issue

THE POLYMORPHISM OF AZAPERONE AND CLOTRIMAZOLE. = LE POLYMORPHISME DE L'AZAPERONE ET DU CLOTRIMAZOLEBORKA L; VALDIMARSDOTTIR S.1975; ACTA PHARM. SUECICA; SUEDE; DA. 1975; VOL. 12; NO 5-6; PP. 479-484; BIBL. 2 REF.Article

CLOTRIMAZOL-CREME UND LOESUNG-KLINISCHE PRUEFUNG IM OFFENEN VERSUCH = LA CREME ET LA SOLUTION DE CLOTRIMAZOLE. ESSAI CLINIQUE DANS UNE RECHERCHE SANS INSUWEUTA H.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 8; PP. 1295-1299; ABS. ANGL.; BIBL. 12REF.Serial Issue

CLOTRIMAZOL-VAGINALTABLETTEN-KLINISCHE PRUEFUNG IM OFFENEN VERSUCH = LES COMPRIMES VAGINAUX DE CLOTRIMAZOLE. ESSAI CLINIQUE DANS UN ESSAI SANS INSU1972; ARZNEIMITTEL-FOSCH.; DTSCH.; DA. 1972; VOL. 22; NO 8; PP. 1291-1294; ABS. ANGL.; BIBL. 1/2P.Serial Issue

  • Page / 25